Overview

A Study of GWP42006 in People With Focal Seizures - Part A

Status:
Completed
Trial end date:
2015-11-01
Target enrollment:
Participant gender:
Summary
To evaluate the pharmacokinetics, safety and tolerability of GWP42006 compared with placebo, in the presence of other antiepileptic drugs (AEDs).
Phase:
Phase 2
Details
Lead Sponsor:
GW Research Ltd